All Industry News

Aurobindo Pharma Limited and COVAXX, a US-based company, have entered into an Exclusive License Agreement to develop, commercialize and manufacture UB-612, the first Multitope Peptide-based Vaccine to fight COVID-19, for India and the United Nations Children’s Fund (UNICEF) agency. COVAXX is currently conducting a Phase 1 clinical trial for the vaccine candidate. Commenting on the […]

It is a most delighted and exciting moment to share that Aurobindo Pharma Foundation, which is the philanthropic arm of Aurobindo Pharma Limited, has been honored as a best CSR (Corporate Social Responsibility) institution under Telangana CSR Leadership awards-2020 in the space of health and nutrition by Asia HRD Congress. Aurobindo Pharma Foundation (APF) is a registered trust and Section […]

Acquisition for an upfront purchase price of $160 million in cash plus up to $140 million on achieving regulatory and sales-based milestones Acquired portfolio includes seven branded oncology injectable products which are currently being marketed. The acquisition also brings-in an experienced branded commercial infrastructure in the US The portfolio is expected to generate a revenue […]

Aurobindo to acquire dermatology and oral solids businesses from Sandoz Inc., USA Acquisition for an upfront purchase price of $0.9 billion in cash including potential upside in near term earn-out and additional potential earn-out on pipeline product in outer years. Aurobindo would become the 2nd largest generic player in the US by number of prescriptions Aurobindo […]

It is an East Windsor Township tradition to recognize businesses – how important they are to the community, how proud the township is of them and how they contribute to the community – every year, Mayor Janice Mironov said There are three awards – the Business Beautification Award, the Community Service Award and the Community […]

Developing and filing for both small-molecule and biological cancer therapies forms a key part of Aurobindo’s strategy to target higher-value products. Aidan Fry examines the company’s plan in this Generic’s bulletin Dec 2017 article.

Frankfurt, 24 October 2017 – Aurobindo Pharma Limited and Generics Bulletin are pleased to announce that Aurobindo has won the Company of the Year, Asia-Pacific Award at the Global Generics & Biosimilars Awards 2017, organized by Generics Bulletin. The Company of the Year, Asia-Pacific Award was sponsored by Eva Pharma and judged by an expert panel. “Congratulations […]

East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from the U.S. Food and Drug Administration for Aurovela™ line of OC tablets. The Division of Bioequivalence has determined Aurobindo Pharma Limited’s Aurovela™ to be bioequivalent and, therefore, therapeutically equivalent to Loestrin® line of oral contraceptive products. Please see table below for each of […]

Hyderabad-based pharma major says US FDA approval likely to come after upcoming audit Hyderabad-based Aurobindo Pharma Limited is hoping to receive three-four product approvals in the oncology space from the US Food and Drug Administration (US FDA) before March 2018. The company’s optimistic prediction about a possible good start in this high-margin product business comes […]

Don’t Harm Patient Access to Affordable Generic Medicines by Chilling Generic Drug Competition. Governor Hogan Should Veto Legislation To Keep Generic Drugs Affordable For Maryland Statement by Chester “Chip” Davis, Jr., President and CEO of the Association for Accessible Medicines Read the full article  

Aurobindo USA is proud to announce and welcome Paul Krauthauser as the company’s Senior Vice President of Commercial Operations reporting to Bob Cunard, Chief Executive Officer. Paul will be responsible for the retail generic business. He has more than 20 years of experience in US Pharmaceutical Sales including but not limited to demand planning, contracting […]

(March 11, 2017) WASHINGTON, DC  – “President Donald Trump’s nomination of Dr. Scott Gottlieb to lead the Food and Drug Administration signals he is serious about increasing access to safe, effective and affordable medicines for Americans while taking a market based, competitive approach towards lowering drug costs. Dr. Gottlieb is one of the most formidable […]